drugset / Trial / NCT00444808

Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs

NCT00444808

Phase 4 Terminated 19 enrolled University of Montreal
RandomizedParallel-groupTriple-blindTreatment

Summary

This study, which will be conducted at the emergency room of the Sacré-Cœur hospital, requires the recruitment of 60 subjects and involves some telephone follow-up. Calcitonin administered as an intranasal spray is already used to relieve pain caused by broken vertebrae and we seek to determine if it can be as efficient in the case of pain caused by broken ribs.This study aims at testing the hypothesis that subjects suffering from the accidental fracture of one or more ribs will get relief through the intranasal spraying of calcitonin and/or will use less opiate medication for pain relief (a combination of oxycodone chlorhydrate and acetaminophen called Percocet®).

Timeline

Start
2007-02
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitonin Protein / enzyme biologic Intranasal

Indications

No indication recorded.